Ziling Liu
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Glioma Diagnosis and Treatment
Papers in
- Oncology 27
- Cancer Immunotherapy and Biomarkers 11
- Lung Cancer Research Studies 10
- Peptidase Inhibition and Analysis 4
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- Hong Wang (2 shared papers)Rui Guo (2 shared papers)Xing Yang (1 shared paper)Shuai Qian (1 shared paper)Jianjun Zhang (1 shared paper)Yuan Gao (1 shared paper)Jing Gao (1 shared paper)Xu Wang (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)Frontiers in Immunology (4 papers)Medicine (4 papers)Frontiers in Oncology (4 papers)Journal of Veterinary Pharmacology and Therapeutics (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ziling Liu
45 papers receiving 654 citations
Ziling Liu's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 201
- Genetics 71
- Cancer Research 96
- Physical and Theoretical Chemistry 56
- Reproductive Medicine 39
Countries citing papers authored by Ziling Liu
This map shows the geographic impact of Ziling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziling Liu more than expected).
Fields of papers citing papers by Ziling Liu
This network shows the impact of papers produced by Ziling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziling Liu. The network helps show where Ziling Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ziling Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunotherapy: a promising approach for glioma treatment Hit paper breakdown → | 2023 | 118 |
| 2 | 2012 | 70 | |
| 3 | 2022 | 49 | |
| 4 | 2015 | 42 | |
| 5 | 2022 | 29 | |
| 6 | 2019 | 28 | |
| 7 | 2019 | 26 | |
| 8 | 2021 | 25 | |
| 9 | 2022 | 24 | |
| 10 | 2015 | 23 | |
| 11 | 2019 | 20 | |
| 12 | 2021 | 18 | |
| 13 | 2022 | 14 | |
| 14 | 2023 | 14 | |
| 15 | 2003 | 14 | |
| 16 | 2022 | 13 | |
| 17 | 2015 | 13 | |
| 18 | 2019 | 11 | |
| 19 | 2021 | 11 | |
| 20 | Low-dose radiation modulates human mesenchymal stem cell proliferation through regulating CDK and Rb. | 2017 | 11 |
About Ziling Liu
Ziling Liu is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Epidemiology, having authored 51 papers that have together received 659 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Research Studies (10 papers), Bladder and Urothelial Cancer Treatments (6 papers), Cancer therapeutics and mechanisms (5 papers), Ovarian cancer diagnosis and treatment (5 papers), Acute Myeloid Leukemia Research (4 papers), Peptidase Inhibition and Analysis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (201 citations), Genetics (71 citations), Cancer Research (96 citations), Physical and Theoretical Chemistry (56 citations) and Reproductive Medicine (39 citations). Ziling Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Hong Wang, Rui Guo, Xing Yang, Shuai Qian, Jianjun Zhang, Yuan Gao, Jing Gao, Xu Wang, Xi Chen and Wěi Li. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Immunology, Medicine, Frontiers in Oncology and Journal of Veterinary Pharmacology and Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.